跳至主要内容
临床试验/NL-OMON45856
NL-OMON45856已完成3 期

Peppermint oil for the treatment of Irritable Bowel Syndrome: optimizing therapeutic strategies using targeted delivery - PERSUADE

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 234 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
234

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age between 18 and 75 years;
  • 2. Diagnosed with Irritable Bowel Syndrome according to the Rome IV criteria:
  • * Recurrent abdominal pain or discomfort, at least 1 days/week for the last 3 months;
  • * Symptom onset at least 6 months prior to diagnosis
  • * Associated with two or more of the following:
  • 1. Pain related with defecation;
  • 2. Pain associated with a change in frequency of stool;
  • 3. Pain associated with a change in form (appearance/consistency) of stool;
  • 3. Based on the medical history and previous examination, no other causes for the abdominal complaints can be defined. Especially no history of:
  • a. Inflammatory Bowel Disease;
  • b. Celiac Disease;
  • c. Thyroid dysfunction (if not well-regulated);
  • If alarm symptoms (including unexplained rectal blood loss or weight loss) are present, a colonoscopy has been performed and was negative for other causes.
  • 4. Women in fertile age (<55 years old) must use contraception or be postmenopausal for at least two years.
  • 5. Average worst abdominal pain score (on 11-point NRS) of > 3, during the two-week run-in period.

排除标准

  • 1. Insufficient fluency of the Dutch language;
  • 2. Any previous use (also incidental use) of peppermint oil capsules in the last 3 months prior to inclusion;
  • 3. The inability to stop regular use of medication affecting the gastro-intestinal system (such as Non Steroidal Anti Inflammatory Drugs (NSAID), laxatives, prokinetics, opioids, smasmolytics and anti-diarrhoeal drugs);
  • a. The use of 1 antidepressant drug is allowed, providing dosing has been stable for > 6 weeks before enrollment;
  • b. The use of 1 proton pump inhibitors (PPI) is allowed, providing dosing has been stable > 6 weeks before enrollment;
  • 4. Previous major abdominal surgery or radiotherapy interfering with gastrointestinal function:
  • a. Uncomplicated appendectomy, cholecystectomy and hysterectomy allowed unless within the past 6 months;
  • b. Other surgery upon judgment of the principle investigator;
  • 5. History of liver disease, cholangitis, achlorhydria, gallstones or other diseases of the gallbladder/biliary system;
  • 6. Pregnancy, lactation;
  • 7. Using drugs of abuse;
  • 8. Known allergic reaction to peppermint.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验